Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Molecular Sciences|January 8, 2025
Exploring the Link Between Psoriasis and Adipose Tissue: One Amplifies the OtherRoberta Di Caprio, Ersilia Nigro, Eugenia Veronica Di Brizzi, et al.
Life (Basel, Switzerland)|July 27, 2024
The Behaviour of IL-6 and Its Soluble Receptor Complex during Different Waves of the COVID-19 PandemicGaetano Di Spigna, Bianca Covelli, Maria Vargas, et al.
Scientific Reports|February 10, 2022
Antiflammatory activity and potential dermatological applications of characterized humic acids from a lignite and a green compostMariavittoria Verrillo, Melania Parisi, Davide Savy, et al.
Experimental and Therapeutic Medicine|October 16, 2019
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatmentLuisa Di Costanzo, Emanuele Scala, Giuseppina Caiazzo, et al.
International Journal of Molecular Sciences|August 10, 2024
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut MicrobiotaPaola Secchiero, Erika Rimondi, Annalisa Marcuzzi, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 17, 2017
Paraoxonases and psoriasis: negative imbalance of antioxidant endogenous mechanismsMaria Schiattarella, Giuseppina Caiazzo, Roberta Di Caprio, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 4, 2015
Psoriasis in melanoma patients: a prospective pilot studyMatteo Megna, Maddalena Napolitano, Nicola Balato, et al.
European Journal of Dermatology : EJD|May 8, 2023
The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patientsRoberta Di Caprio, Lidia Sacchelli, Gaetano Di Spigna, et al.
Dermatology Practical & Conceptual|October 25, 2024
A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?Eugenia Veronica Di Brizzi, Stefano Caccavale, Roberta Di Caprio, et al.
Pageof 3